Macrophage scavenger receptors: Tumor support and tumor inhibition

Elena Kazakova1,2, Pavel Iamshchikov1,2, Irina Larionova1,2,3

  • 1Laboratory of translational cellular and molecular biomedicine, National Research Tomsk State University, Tomsk, Russia.

Frontiers in Oncology
|January 23, 2023
PubMed

Insights

Macrophage scavenger receptors (SRs) play dual roles in cancer, influencing tumor growth and patient outcomes. Understanding these roles is crucial for developing targeted anti-cancer therapies.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) are key components of the tumor microenvironment (TME), comprising up to 50% of tumor mass.
  • Scavenger receptors (SRs) on TAMs mediate interactions within the TME, recognizing and internalizing various ligands.
  • SRs are implicated in regulating cancer cell biology, immune responses, angiogenesis, and metabolism within the TME.

Purpose of the Study:

  • To review the current understanding of macrophage scavenger receptors (SRs) in tumor development.
  • To evaluate the significance of TAM-expressed SRs as cancer biomarkers and their prognostic value.
  • To explore the therapeutic potential of targeting SRs in anti-cancer strategies.

Main Methods:

  • Comprehensive literature review of studies on TAM-expressed SRs in animal models and human cancer patients.
  • Analysis of data on the functional roles and prognostic significance of SRs across various human cancer types.
  • Discussion of SRs' involvement in regulating cancer cell biology, TME interactions, and metabolism.

Main Results:

  • TAM-expressed SRs exhibit both tumor-promoting and tumor-inhibiting functions.
  • Significant variations exist in the prognostic and functional roles of SRs depending on the specific cancer type.
  • SRs influence cancer cell biology, cell-cell/matrix interactions, immune status, angiogenesis, and intratumoral metabolism.

Conclusions:

  • Macrophage scavenger receptors are critical regulators of tumor progression and possess prognostic significance in cancer.
  • Targeting tumor-promoting SRs presents a promising therapeutic avenue for anti-cancer therapy.
  • Further research into cancer-type-specific roles of SRs is warranted for effective therapeutic development.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K